COMMUNIQUÉS West-GlobeNewswire
-
KFSHRC Showcases Medical Education Innovations at AMEE 2024 Switzerland
20/08/2024 - 19:00 -
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
20/08/2024 - 21:35 -
Galapagos receives transparency notification from FMR LLC
20/08/2024 - 22:01 -
Tectonic Therapeutic to Participate in September Investor Conferences
20/08/2024 - 22:01 -
Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates
20/08/2024 - 22:05 -
OrthoPediatrics Corp. to Host Investor Day on September 12, 2024
20/08/2024 - 22:05 -
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
20/08/2024 - 22:05 -
Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
20/08/2024 - 22:05 -
ANY LAB TEST NOW AND ARCPOINT CREATE LARGEST FRANCHISE DIRECT ACCESS LAB TESTING GROUP IN THE UNITED STATES
20/08/2024 - 22:45 -
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
19/08/2024 - 13:00 -
Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs & Quality Assurance Officer
19/08/2024 - 13:00 -
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
19/08/2024 - 13:00 -
Kraig Biocraft Laboratories Successfully Completes Third Commercial Spider Silk Production Cycle
19/08/2024 - 13:05 -
BridgeBio Launches MyAchonJourney, a New Resource for Families Navigating Achondroplasia
19/08/2024 - 13:30 -
Calibre Scientific Acquires Industrial Glassware, a U.S. Manufacturer and Provider of Laboratory Supplies and Consumables
19/08/2024 - 13:53 -
Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19/08/2024 - 14:00 -
Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri
19/08/2024 - 14:00 -
Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes
19/08/2024 - 14:00 -
ImmuneSensor Therapeutics Receives Clearance from Australian Regulators to Initiate a First-in-Human Phase 1 Clinical Trial of cGAS inhibitor Drug Candidate, IMSB301
19/08/2024 - 14:00
Pages